Is AIMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AIMD. It does not provide personalized investment advice.

AIMD (Ainos, Inc. Common Stock) Stock Analysis - Financials

Ainos, Inc. Common Stock (AIMD) is a publicly traded Healthcare sector company. As of November 12, 2026, AIMD trades at $0.52 with a market cap of $3.47M and a P/E ratio of -0.39. AIMD moved +6.44% today. Year to date, AIMD is -72.92%; over the trailing twelve months it is -84.68%. Its 52-week range spans $0.43 to $4.50. Rallies surfaces AIMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AIMD's key financials?

AIMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AIMD recently traded at $0.52. Market cap is $3.47M. P/E ratio is -0.39. Revenue is $124.16K.

AIMD Key Metrics

Key financial metrics for AIMD
Metric	Value
Price	$0.52
Market Cap	$3.47M
P/E Ratio	-0.39
EPS	$-3.46
Dividend Yield	0.00%
52-Week High	$4.50
52-Week Low	$0.43
Volume	155.83K
Avg Volume	0
Revenue (TTM)	$124.16K
Net Income	$-14.77M
Gross Margin	82.89%

AIMD Analyst Consensus

AIMD analyst coverage data. Average price target: $0.00.

Common questions about AIMD

What are AIMD's key financials?: AIMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AIMD recently traded at $0.52. Market cap is $3.47M. P/E ratio is -0.39. Revenue is $124.16K.
Is AIMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AIMD. It does not provide personalized investment advice.